In clinical settings, AD severity is correlated with SEB-induced apoptosis (Kędzierska et al., 2005), and therapy with infliximab, a TNFα inhibitor, significantly improves clinical parameters, although this improvement is not sustained (Jacobi et al., 2005). Here, TNF is linked to Alzheimer disease.